Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma
dc.contributor.author | Collins, Katrina | |
dc.contributor.author | Hwang, Michael | |
dc.contributor.author | Antic, Tatjana | |
dc.contributor.author | Paintal, Ajit | |
dc.contributor.author | Argani, Pedram | |
dc.contributor.author | Matoso, Andres | |
dc.contributor.author | Gopinath, Arun | |
dc.contributor.author | Baskovich, Brett | |
dc.contributor.author | Mehra, Rohit | |
dc.contributor.author | Williamson, Sean R. | |
dc.contributor.author | Idrees, Muhammad T. | |
dc.contributor.author | Barletta, Justine A. | |
dc.contributor.author | Anderson, William J. | |
dc.contributor.author | Hirsch, Michelle S. | |
dc.contributor.author | Hornick, Jason L. | |
dc.contributor.author | Acosta, Andres M. | |
dc.date.accessioned | 2022-11-09T21:20:14Z | |
dc.date.available | 2023-12-09 16:20:08 | en |
dc.date.available | 2022-11-09T21:20:14Z | |
dc.date.issued | 2022-11 | |
dc.identifier.citation | Collins, Katrina; Hwang, Michael; Antic, Tatjana; Paintal, Ajit; Argani, Pedram; Matoso, Andres; Gopinath, Arun; Baskovich, Brett; Mehra, Rohit; Williamson, Sean R.; Idrees, Muhammad T.; Barletta, Justine A.; Anderson, William J.; Hirsch, Michelle S.; Hornick, Jason L.; Acosta, Andres M. (2022). "Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma." Histopathology (5): 577-586. | |
dc.identifier.issn | 0309-0167 | |
dc.identifier.issn | 1365-2559 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175126 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | renal cell carcinoma | |
dc.subject.other | mutation | |
dc.subject.other | merlin | |
dc.subject.other | NF2 | |
dc.subject.other | renal neoplasm | |
dc.title | Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Microbiology and Immunology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175126/1/his14731.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175126/2/his14731_am.pdf | |
dc.identifier.doi | 10.1111/his.14731 | |
dc.identifier.source | Histopathology | |
dc.identifier.citedreference | Malouf GG, Flippot R, Dong Y et al. Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. Sci. Rep. 2020; 10; 701. | |
dc.identifier.citedreference | Pal SK, Choueiri TK, Wang K et al. Characterization of clinical cases of collecting duct carcinoma of the kidney assessed by comprehensive genomic profiling. Eur. Urol. 2016; 70; 516 – 521. | |
dc.identifier.citedreference | Chang LS, Akhmametyeva EM, Wu Y, Zhu L, Welling DB. Multiple transcription initiation sites, alternative splicing, and differential polyadenylation contribute to the complexity of human neurofibromatosis 2 transcripts. Genomics 2002; 79; 63 – 76. | |
dc.identifier.citedreference | Schmucker B, Tang Y, Kressel M. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules. Hum. Mol. Genet. 1999; 8; 1561 – 1570. | |
dc.identifier.citedreference | Wang G, Amin MB, Grossmann P et al. Renal cell tumor with sex-cord/gonadoblastoma-like features: Analysis of 6 cases. Virchows Arch. 2022; 480; 349 – 358. | |
dc.identifier.citedreference | Yakirevich E, Pavlick DC, Perrino CM et al. NF2 tumor suprressor gene inactivation in advanced papillary renal cell carcinoma. Am. J. Surg. Pathol. 2021; 45; 716 – 718. | |
dc.identifier.citedreference | Lobo J, Ohashi R, Amin MB, Berney DM, Compérat EM, Cree IA, Gill AJ, Hartmann A, Menon S, Netto GJ, Raspollini MR, Rubin MA, Tan PH, Tickoo SK, Tsuzuki T, Turajlic S, Zhou M, Srigley JR, Moch H WHO 2022 landscapre of papillary and chromophobe renal cell carcinoma. Histopathology. 2022. Online ahead of print. | |
dc.identifier.citedreference | Srigley JR, Delahunt B, Eble JN et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am. J. Surg. Pathol. 2013; 37; 1469 – 1489. | |
dc.identifier.citedreference | Gopinath A, Mubeen A, Jamal M, Mohammed I, Gopireddy DR, Baskovich B. Biphasic hyalinizing Psammomatous renal cell carcinoma: Another provisional entity emerging from the papillary renal cell carcinoma Pandora’s box. Int. J. Surg. Pathol. 2021; 29; 783 – 787. | |
dc.identifier.citedreference | Wang XT, Xia QY, Fang R et al. Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: Further support for the newly proposed entity. Hum. Pathol. 2022; 123; 102 – 112. | |
dc.identifier.citedreference | Paintal A, Tjota MY, Wang P et al. NF2-mutated renal carcinomas have common morphologic features which overlap with biphasic hyalinizing Psammomatous renal cell carcinoma: A comprehensive study of 14 cases. Am. J. Surg. Pathol. 2022; 46; 617 – 627. | |
dc.identifier.citedreference | Argani P, Reuter VE, Eble JN et al. Biphasic hyalinizing Psammomatous renal cell carcinoma (BHP RCC): A distinctive neoplasm associated with somatic NF2 mutations. Am. J. Surg. Pathol. 2020; 44; 901 – 916. | |
dc.identifier.citedreference | Petrilli AM, Fernández-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene 2016; 35; 537 – 548. | |
dc.identifier.citedreference | Cooper J, Giancotti FG. Molecular insights into NF2/Merlin tumor suppressor function. FEBS Lett. 2014; 588; 2743 – 2752. | |
dc.identifier.citedreference | Chapel DB, Hornick JL, Barlow J, Bueno R, Sholl LM. Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Mod. Pathol. 2022. Online ahead of print. | |
dc.identifier.citedreference | Chen YB, Xu J, Skanderup AJ et al. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nat. Commun. 2016; 7; 13131. | |
dc.identifier.citedreference | Mehra R, Vats P, Cieslik M et al. Biallelic alteration and dysregulation of the hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney. Cancer Discov. 2016; 6; 1258 – 1266. | |
dc.identifier.citedreference | Rybarczyk A, Klacz J, Wronska A, Matuszewski M, Kmiec Z, Wierzbicki PM. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome. Oncol. Rep. 2017; 38; 427 – 439. | |
dc.identifier.citedreference | Zhang N, Bai H, David KK et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev. Cell 2010; 19; 27 – 38. | |
dc.identifier.citedreference | Gleeson JP, Nikolovski I, Dinatale R et al. Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma. Clin. Cancer Res. 2021; 27; 2910 – 2919. | |
dc.identifier.citedreference | Linehan WM, Spellman PT, Ricketts CJ et al. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 2016; 374; 135 – 145. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.